Legend Biotech
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $307,636 | $272,330 | $255,058 | $195,053 |
Gross Profit | 183,597 | 157,024 | 157,067 | 123,709 |
EBITDA | -7,733 | -33,194 | -113,722 | -88,870 |
EBIT | -19,785 | -39,073 | -119,576 | -94,069 |
Net Income | -31,034 | -39,689 | -125,380 | -100,916 |
Net Change In Cash | 307,636 | 272,330 | 255,058 | 195,053 |
Free Cash Flow | -126,559 | 23,796 | -22,266 | -105,756 |
Cash | 901,903 | 278,893 | 266,586 | 441,702 |
Basic Shares | 184,733 | 184,636 | 184,135 | 183,762 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,031,621 | $627,241 | $285,143 | $117,005 |
Gross Profit | 622,441 | 392,660 | 140,929 | 51,642 |
EBITDA | -107,784 | -113,159 | -477,873 | -416,536 |
EBIT | -136,861 | -136,518 | -498,324 | -434,928 |
Net Income | -297,584 | -177,026 | -518,254 | -446,349 |
Net Change In Cash | 1,031,621 | 627,241 | 285,143 | 117,005 |
Free Cash Flow | -168,043 | -158,138 | -415,998 | -223,556 |
Cash | 901,903 | 286,749 | 1,277,713 | 786,031 |
Basic Shares | 184,320 | 182,851 | 176,082 | 159,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.16 |
2025-09-30 | -$0.11 |
2025-06-30 | -$0.34 |
